Clinical Trials Browser

Interventional × Thromboembolism × PEGPH20 × Clear all

NCT02921022 2025-11-26

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Phase NA Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism